Smart Syringes Market Segmentation, Analysis by Production, Consumption, Revenue and Growth Rate by 2030

At an estimated value of over USD 6.78 billion in 2019, the Global Smart Syringes Market is predicted to thrive at a CAGR of 7.9%and valued at over USD 15.65 billion over the forecast year 2020-2030.

Smart syringes are medical devices designed with safety mechanisms to avoid the reuse of syringes and regulate the unsafe injection practices. These syringes are equipped with its own read/write chip containing preset parameters, ranges, and usage tracking. It also prevents needlestick injuries to the patient and helps in minimizing transmission of blood-borne diseases such as hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). These syringes are used in various applications including drug delivery, vaccination, and blood specimen collection. There are different types of smart syringes such as passive safety syringes, auto disable (AD) syringes, and active safety syringes that are used according to the application. For the activation of the safety feature, the passive safety syringes usually retract automatically after the use, while active safety needles require manual activation. On the other hand, auto-disable (AD) syringes automatically get disabled after one use.

Access Full Description of this report at:-

https://www.nextmsc.com/report/smart-syringes-market

Competitive Landscape :

Maximum growth opportunities make the Smart Syringes market highly competitive. Some of the major players in the market are Smiths Group Plc, Baxter International Inc., B. Braun Melsungen AG, Terumo Medical Corp., Unilife Corp., Revolutions Medical Corp., Retractable Technologies Inc, Medtronic Plc (Covidien), Becton, Dickinson and Company., and many more. A number of developmental strategies have been adopted by companies in the past few years. For instance, in December 2020, BD (Becton, Dickinson and Company) planned to invest about $1.2 billion over a 4-year period to expand as well as add a new manufacturing facility in Europe and to upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six global manufacturing locations. In May 2020, Baxter International Inc. announced the approval of CE marking and regulatory from Therapeutic Goods Administration (TGA), Australia for the Evo IQ Syringe Infusion System.

Request sample copy of this report at:-

https://www.nextmsc.com/smart-syringes-market/request-sample

Market Segmentations and Scope of the Study:

The global Smart Syringes market share is segmented on the basis of product type, age group, application, end user, and geography. On the basis of product type, the market is segmented into active safety syringes, passive safety syringes, and auto disable syringes. On the basis of age group, the market is segmented into adults and pediatrics. By application, the market is divided into vaccination, drug delivery, and blood specimen collection. On the basis of end user, the market is segmented into hospitals & HMOs, family practices, diabetic patients, psychiatrics, and others. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.

Geographical Analysis:

In terms of geography, North America held major share of the smart syringes market in 2019. This is due to the extensive adoption of safety syringes in this region due to increasing awareness related with needle stick injuries. Also, constant improvements across healthcare practices in the region fuels the market growth. However, Asia-pacific is expected to grow rapidly with increasing market size. This is attributed to the increased healthcare expenses owing to the growing disposable income in developing countries across the region.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.